Dermatol. praxi. 2025;19(4):173-176 | DOI: 10.36290/der.2025.031

Aesthetic treatment combinations

MUDr. Kevin Machů
DermaMedEst, s. r. o., a AestheScar s. r. o., Praha

Aesthetic treatment combinations are nowadays an integral part of dermatological practice. A properly chosen strategy allows to achieve natural and long-lasting results, as individual techniques target different skin layers and complement one another. The article focuses on how to combine and time botulinum toxin, dermal fillers, lasers, radiofrequency microneedling, threads, and chemical peels in order to achieve a sy­nergistic effect while minimizing the risk of complications. Also discussed is the use of combination protocols in rosacea, acne, scars, pigment spots as well as in treating and preventing skin ageing. The key to success is an individual plan that respects the patient's needs and allows to combine different procedures safely and effectively. Modern aesthetic medicine is thus moving towards solutions that place emphasis on harmony, balance, and gradual improvement in appearance.

Keywords: esthetic treatment combinations, botulinum toxin, fillers, lasers, peels, skin ageing.

Accepted: December 3, 2025; Published: December 16, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Machů K. Aesthetic treatment combinations. Dermatol. praxi. 2025;19(4):173-176. doi: 10.36290/der.2025.031.
Download citation

References

  1. Park KY, López Gehrke I. Combined multilevel anti-aging strategies and practical applications of dermocosmetics in aesthetic procedures. J Eur Acad Dermatol Venereol. 2024 Jul;38 Suppl 4:23-35. doi: 10.1111/jdv.19975. PMID: 38881448. Go to original source... Go to PubMed...
  2. Anzengruber F, Czernielewski J, Conrad C, et al. Swiss S1 guideline for the treatment of rosacea. J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1775-1791. doi: 10.1111/jdv.14349. Epub 2017 Aug 21. PMID: 28833645. Go to original source... Go to PubMed...
  3. Carruthers JDA, Glogau RG, Blitzer A, et al. Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies - Consensus Recommendations. Plastic and Reconstructive Surgery 121(5):p 5S-30S, May 2008. doi: 10.1097/PRS.0b013e31816de8d0. Go to original source... Go to PubMed...
  4. Piccolo D, Fusco I, Zingoni T, et al. Effective Treatment of Rosacea and Other Vascular Lesions Using Intense Pulsed Light System Emitting Vascular Chromophore-Specific Wavelengths: A Clinical and Dermoscopical Analysis. J. Clin. Med. 2024;13:1646. https://doi.org/10.3390/jcm13061646. Go to original source... Go to PubMed...
  5. Lee MWC. Combination 532-nm and 1064-nm lasers for noninvasive skin rejuvenation and toning. Arch Dermatol. 2003 Oct;139(10):1265-1276. doi:10.1001/archderm.139.10.1265. Go to original source... Go to PubMed...
  6. Jurairattanaporn N, Amornpetkul W, Rutnin S, et al. The effect of combined hyaluronic acid filler injection and radiofrequency treatment: A clinic histological analysis. J Cosmet Dermatol. 2023 Mar;22(3):798-803. doi: 10.1111/jocd.15509. Go to original source... Go to PubMed...
  7. Kalra R. Use of barbed threads in facial rejuvenation. Indian J Plast Surg. 2008 Oct;41(Suppl):S93-S100. PMID: 20174549; PMCID: PMC2825122. Go to original source...
  8. Soleymani T, Lanoue J, Rahman Z. A Practical Approach to Chemical Peels: A Review of Fundamentals and Step-by-step Algorithmic Protocol for Treatment. J Clin Aesthet Dermatol. 2018 Aug;11(8):21-28. Epub 2018 Aug 1. PMID: 30214663; PMCID: PMC6122508.
  9. Huerth K, Ohanenye C, Quartey A, et al. Established and Emerging Laser Treatments for Acne Vulgaris in Diverse Skin Types. J Clin Aesthet Dermatol. 2025 Jun;18(6):41-48. PMID: 40575606; PMCID: PMC12189219.
  10. Passeron T, Lim HW, Goh CL, et al. Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1460-1469. doi: 10.1111/jdv.17242. Epub 2021 May 4. PMID: 33764577; PMCID: PMC8252523. Go to original source... Go to PubMed...
  11. Niwa Massaki AB, Eimpunth S, Fabi SG, et al. Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up. Lasers Surg Med. 2013 Feb;45(2):95-101. doi: 10.1002/lsm.22100. Epub 2012 Dec 19. PMID: 23255085. Go to original source... Go to PubMed...
  12. Piccolo D, Fusco I, Crisman G, et al. Efficacy and Safety of Q-Switched 1064/532 nm Nd:YAG Lasers on Benign Hypermelanosis in Dark-Skinned Individuals-A Preliminary Study. J Clin Med. 2024 Mar 12;13(6):1615. doi: 10.3390/jcm13061615. PMID: 38541841; PMCID: PMC10971304. Go to original source... Go to PubMed...
  13. Michon A. Botulinum toxin for cosmetic treatments in young adults: An evidence-based review and survey on current practice among aesthetic practitioners. J Cosmet Dermatol. 2023 Jan;22(1):128-139. doi: 10.1111/jocd.15513. Epub 2022 Nov 29. PMID: 36445847. Go to original source... Go to PubMed...
  14. Binder WJ. Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins. Arch Facial Plast Surg. 2006 Nov-Dec;8(6):426-31. doi: 10.1001/archfaci.8.6.426. PMID: 17116793. Go to original source... Go to PubMed...
  15. Levy T, Lerman I, Waibel J, et al. Expert Consensus on Clinical Recommendations for Fractional Ablative CO2 Laser, in Facial Skin Rejuvenation Treatment. Lasers Surg Med. 2025 Jan;57(1):15-26. doi: 10.1002/lsm.23850. Epub 2024 Oct 21. PMID: 39434507; PMCID: PMC11776446. Go to original source... Go to PubMed...
  16. Rorteau J, Chevalier FP, Bonnet S, et al. Maintenance of Chronological Aging Features in Culture of Normal Human Dermal Fibroblasts from Old Donors. Cells. 2022 Mar 2;11(5):858. doi: 10.3390/cells11050858. PMID: 35269480; PMCID: PMC8909060. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.